Abstract
p16 inhibits cyclin-dependent kinases and regulates senescence-mediated arrest as well as p21. Nuclear p16 promotes G1 cell cycle arrest and cellular senescence. In various glomerular diseases, nuclear p16 expression is associated with disease progression. Therefore, the location of p16 is important. However, the mechanism of p16 trafficking between the nucleus and cytoplasm is yet to be fully investigated. TGF-β1, a major cytokine involved in the development of kidney diseases, can upregulate p21 expression. However, the relationship between TGF-β1 and p16 is poorly understood. Here, we report the role of podocyte TGF-β1 in regulating the p16 behavior in glomerular endothelial cells. We analyzed podocyte-specific TGF-β1 overexpression mice. Although p16 was found in the nuclei of glomerular endothelial cells and led to endothelial cellular senescence, the expression of p16 did not increase in glomeruli. In cultured endothelial cells, TGF-β1 induced nuclear translocation of p16 without increasing its expression. Among human glomerular diseases, p16 was detected in the nuclei of glomerular endothelial cells. In summary, we demonstrated the novel role of podocyte TGF-β1 in managing p16 behavior and cellular senescence in glomeruli, which has clinical relevance for the progression of human glomerular diseases.
Highlights
P16 inhibits cyclin-dependent kinases and regulates senescence-mediated arrest as well as p21
We demonstrated that podocyte TGF-β1 could affect the behavior of p16 in glomerular endothelial cells in vivo and in vitro
The most crucial finding in this study is that TGF-β1 was involved in senescence-related pathways via p21 and p16 in glomeruli in vivo and in vitro, because p16 and p21 are major molecules responsible for cellular senescence
Summary
P16 inhibits cyclin-dependent kinases and regulates senescence-mediated arrest as well as p21. We report the role of podocyte TGF-β1 in regulating the p16 behavior in glomerular endothelial cells. P16 was found in the nuclei of glomerular endothelial cells and led to endothelial cellular senescence, the expression of p16 did not increase in glomeruli. We demonstrated the novel role of podocyte TGFβ1 in managing p16 behavior and cellular senescence in glomeruli, which has clinical relevance for the progression of human glomerular diseases. TGF-β1 is well-known as a major cytokine involved in the development of kidney d iseases[14,15] It has been implicated in the regulation of cell proliferation, hypertrophy, apoptosis and fibrogenesis[16]. To clarify the role of local TGF-β1 expression, Ghayur et al induced adenovirus-mediated gene transfer of TGF-β1 mainly in glomerular endothelial cells. The effect of the long-term locally produced TGF-β1 on glomerular pathological changes has not been clarified
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
